Industry news

Four UK universities received research grants to fight AMR

GMP News

Multimillion grants have been awarded to four UK universities to conduct interdisciplinary research into the biological, social, cultural and economic drivers behind the development of antimicrobial resistance (AMR) in low and middle income countries (LMICs) opens in new window.

Russia is developing a recombinant cholera vaccine

GMP News

Scientists from the State Research Institute of Highly Pure Biopreparations of the FMBA of Russia are developing a cholera vaccine. Unlike traditional vaccines, it will be created without using any living bacteria fragments. New vaccine will include recombinant proteins that induce the body’s immune response.

'Big data' analysis links herpes virus to Alzheimer's development

Amirah Al Idrus / FierceBiotech

The idea that viruses might play a role in Alzheimer's disease is decades old but has never been definitively proven. A "multi-omic" analysis of more than 900 donor brains linked the amount of herpes virus in a person's brain to the presence of Alzheimer's markers, such as amyloid plaques. The discovery could open up new possibilities for Alzheimer's treatment, such as antiviral and immune therapy. 

Researchers unveil “unprecedentedly sensitive” biochips

Marchmont Innovation News

Researchers at the Moscow Institute of Physics and Technology (MIPT), a top technology university in Russia, have developed new biosensor chips of “unprecedentedly high sensitivity.” They replaced gold, which is typically used in such devices, with copper. The approach is expected to not only lower the cost of the end solutions but also make biosensor manufacturing technology much simpler, the developers said. 

No pharma Grand Prix—again—at Cannes Lions Health, but record number of awards for drugmakers

Beth Snyder Bulik / FiercePharma

For the second year in a row, there is no grand prize winner in the pharma category at Cannes Lions Health. The big idea award, called the Grand Prix, eluded the field again, despite a pharma-heavy short list. But while pharma marketers may be disappointed, they still have plenty of reason to celebrate. Sixteen different pharma companies made the awards shortlist and 10 won gold, silver or bronze Lions. That’s a sharp uptick from last year when only nine were finalists and three picked up awards.

Drug shortages again on the rise after 5 years of improvements, FDA says

Eric Palmer / FiercePharma

After 5 years of declines in the number of new drug shortages in the U.S., they jumped to 39 last year from 26 in the two preceding years. And while that is a far cry from the peak of more than 250 registered in 2011, the FDA acknowledges that many of the current shortages have been for critical drug products and “are having a tangible impact on patients.”

Pfizer’s 'Living With Cancer' wowed Cannes attendees, if not the pharma jury

Beth Snyder Bulik / FiercePharma

A Pfizer documentary film about five patients living with cancer may have inspired more fanfare at Cannes Lions Health than it did in the eight months since its launch. The “This is Living With Cancer” film and its associated campaign was shortlisted for a pharma award at the annual ad festival and was heaped with praise after Pfizer presented it in an open session.

21 June 2018

Marinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 Index

Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, announced that it will be added to the Russell 2000® and Russell 3000® Indexes, effective Friday, June 22, 2018, after market close. 

21 June 2018

EvaluatePharma World Preview 2018, Outlook to 2024

EvaluatePharma® World Preview 2018, Outlook to 2024

And according to EvaluatePharma’s World Preview 2018, we are looking at an industry set to experience sales accelerating from the sluggish levels following the financial crisis, to annual compound growth of over 6% between now and 2024. 

Russian equipment for storage of thermolabile drugs was delivered to China

GMP News

POZIS JSC, an affiliate of Techmash concern of Rostec Corporation, for the first time delivered Russian medical equipment to Hong Kong. Under the contract, the customer received HF-140 POZIS, pharmaceutical refrigerators designed for storage of thermolabile drugs, and RBC-2, new generation compact bactericidal recirculators for air disinfection.